October 10, 2013

MSF's Judit Rius explains how a trade agreement could delay the development of generic medications, making lifesaving drugs unaffordable for many people.


View external media

Related News & Publications

Be part of MSF

Our supporters, donors and fundraisers are a vital part of the MSF movement.

Find out how you can support MSF's lifesaving work.

Learn more